A MultiAssayExperiment
containing RNA microarray, mircoRNA and RNA sequencing data from the NCI60, subset to cell-lines in NCI-ALMANAC
Source: R/CBWWorkshop2024_NCI-Almanac_data.R
NCI60_molecular_data.Rd
This data has been precurated for inclusion in the NCI60_2021 PharmacoSet,
hosted on www.ORCESTRA.ca and downloadable from PharmacoGx
via the
downloadPSet
function. This data has already been subset to contain only
cancer cell-lines also present in the NCI-ALMANAC dataset.
Usage
data(NCI60_molecular_data)
CBWWorkshop2024::NCI60_molecular_data
References
Shoemaker, R. H. (2006). The NCI60 human tumour cell line anticancer drug screen. Nature Reviews Cancer, 6(10), 813–823. https://doi.org/10.1038/nrc1951
Holbeck, S. L., Camalier, R., Crowell, J. A., Govindharajulu, J. P., Hollingshead, M., Anderson, L. W., Polley, E., Rubinstein, L., Srivastava, A., Wilsker, D., Collins, J. M., & Doroshow, J. H. (2017). The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity. Cancer Research, 77(13), 3564–3576. https://doi.org/10.1158/0008-5472.CAN-17-0489